This is shown by an incident in Europe involving the production of neutralizing antibodies that cross-reacted with intrinsic erythropoietin, resulting in pure red cell aplasia in approximately 200 patients treated with various epoetin alfa and epoetin beta preparations between 1998 and 2003 [162]. Here, EPO is linked to Pure red cell aplasia.